English
简体中文
Total: £ 56.28
Published Date: 2026-04-16 | Pages: 125 | Tables: 120 | Pharma & Healthcare
The global Low Molecular Weight Heparin API market was valued at US$ 875 million in 2025 and is anticipated to reach US$ 1491 million by 2032, at a CAGR of 8.0% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Low Molecular Weight Heparin API competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Heparin is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots. Most of the Heparin product is existed in a form of Heparin Sodium or Heparin Calcium. In this report, we mainly study the low molecular weight heparin API.
The Low Molecular Weight Heparin (LMWH) API market plays a crucial role in the global pharmaceutical industry due to the widespread use of LMWHs in the prevention and treatment of blood clot-related disorders, such as deep vein thrombosis (DVT) and pulmonary embolism (PE). LMWH APIs are preferred in clinical settings for their favorable pharmacological properties, including better bioavailability, longer half-life, and reduced risk of side effects compared to unfractionated heparin. The increasing prevalence of cardiovascular diseases and venous thromboembolism, aging populations, and a rise in surgical procedures worldwide have significantly driven demand for LMWH-based therapies.
The North American and European markets lead in demand due to a high prevalence of thrombosis-related conditions and advanced healthcare infrastructure. Asia-Pacific is emerging as a growth market, driven by increased healthcare spending and the rise of generics.
Low Molecular Weight Heparin API segment market, the Enoxaparin Sodium holds an important share, and it is expected to reach a value of US$ 1,258.82 million by 2030, at a CAGR of 12.46% during 2024 and 2030.
The global key companies of Low Molecular Weight Heparin API include Yantai Dongcheng Pharmaceutical, Shenzhen Hepalink Pharmaceutical, Nanjing King-friend Biochemical Pharmaceutical, Changzhou Qianhong Biopharma, and Qingdao Jiulong Biopharmaceutical, etc. In 2023, the global five largest players hold a share approximately 72.91% in terms of revenue.
This report delivers a comprehensive overview of the global Low Molecular Weight Heparin API market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Low Molecular Weight Heparin API. The Low Molecular Weight Heparin API market size, estimates, and forecasts are provided in terms of sales volume (Billion Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Low Molecular Weight Heparin API market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Low Molecular Weight Heparin API manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Yantai Dongcheng Pharmaceutical
Shenzhen Hepalink Pharmaceutical
Nanjing King-friend
Changzhou Qianhong Biopharma
Qingdao Jiulong Biopharmaceutical
Dongying Tiandong Pharmaceutical
Yino Pharma
Opocrin
Hebei Changshan
Hubei Enoray Biopharmaceutical
Nanjing Nanda Pharmaceutical
Cisen Pharmaceutical
Segment by Type
Low Molecular Weight Heparin Sodium
Low Molecular Weight Heparin Calcium
by Application
Enoxaparin Sodium
Nadroparin Calcium
Dalteparin Sodium
Tinzaparin Sodium
Parnaparin Sodium
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Low Molecular Weight Heparin API manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Low Molecular Weight Heparin API sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Low Molecular Weight Heparin API Market Overview
1.1 Product Definition
1.2 Low Molecular Weight Heparin API by Type
1.2.1 Global Low Molecular Weight Heparin API Market Value by Type: 2025 vs 2032
1.2.2 Low Molecular Weight Heparin Sodium
1.2.3 Low Molecular Weight Heparin Calcium
1.3 Low Molecular Weight Heparin API by Application
1.3.1 Global Low Molecular Weight Heparin API Market Value by Application: 2025 vs 2032
1.3.2 Enoxaparin Sodium
1.3.3 Nadroparin Calcium
1.3.4 Dalteparin Sodium
1.3.5 Tinzaparin Sodium
1.3.6 Parnaparin Sodium
1.4 Global Low Molecular Weight Heparin API Market Size Estimates and Forecasts
1.4.1 Global Low Molecular Weight Heparin API Revenue 2021–2032
1.4.2 Global Low Molecular Weight Heparin API Sales 2021–2032
1.4.3 Global Low Molecular Weight Heparin API Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Low Molecular Weight Heparin API Market Competition by Manufacturers
2.1 Global Low Molecular Weight Heparin API Sales Market Share by Manufacturers (2021–2026)
2.2 Global Low Molecular Weight Heparin API Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Low Molecular Weight Heparin API Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Low Molecular Weight Heparin API, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Low Molecular Weight Heparin API, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Low Molecular Weight Heparin API, Product Types and Applications
2.7 Global Key Manufacturers of Low Molecular Weight Heparin API, Date of Entry into the Industry
2.8 Global Low Molecular Weight Heparin API Market Competitive Situation and Trends
2.8.1 Global Low Molecular Weight Heparin API Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Low Molecular Weight Heparin API Players Market Share by Revenue
2.8.3 Global Low Molecular Weight Heparin API Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Low Molecular Weight Heparin API Market Scenario by Region
3.1 Global Low Molecular Weight Heparin API Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Low Molecular Weight Heparin API Sales by Region: 2021–2032
3.2.1 Global Low Molecular Weight Heparin API Sales by Region: 2021–2026
3.2.2 Global Low Molecular Weight Heparin API Sales by Region: 2027–2032
3.3 Global Low Molecular Weight Heparin API Revenue by Region: 2021–2032
3.3.1 Global Low Molecular Weight Heparin API Revenue by Region: 2021–2026
3.3.2 Global Low Molecular Weight Heparin API Revenue by Region: 2027–2032
3.4 North America Low Molecular Weight Heparin API Market Facts & Figures by Country
3.4.1 North America Low Molecular Weight Heparin API Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Low Molecular Weight Heparin API Sales by Country (2021–2032)
3.4.3 North America Low Molecular Weight Heparin API Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Low Molecular Weight Heparin API Market Facts & Figures by Country
3.5.1 Europe Low Molecular Weight Heparin API Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Low Molecular Weight Heparin API Sales by Country (2021–2032)
3.5.3 Europe Low Molecular Weight Heparin API Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Low Molecular Weight Heparin API Market Facts & Figures by Region
3.6.1 Asia Pacific Low Molecular Weight Heparin API Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Low Molecular Weight Heparin API Sales by Region (2021–2032)
3.6.3 Asia Pacific Low Molecular Weight Heparin API Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Low Molecular Weight Heparin API Market Facts & Figures by Country
3.7.1 Latin America Low Molecular Weight Heparin API Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Low Molecular Weight Heparin API Sales by Country (2021–2032)
3.7.3 Latin America Low Molecular Weight Heparin API Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Low Molecular Weight Heparin API Market Facts & Figures by Country
3.8.1 Middle East and Africa Low Molecular Weight Heparin API Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Low Molecular Weight Heparin API Sales by Country (2021–2032)
3.8.3 Middle East and Africa Low Molecular Weight Heparin API Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Low Molecular Weight Heparin API Sales by Type (2021–2032)
4.1.1 Global Low Molecular Weight Heparin API Sales by Type (2021–2026)
4.1.2 Global Low Molecular Weight Heparin API Sales by Type (2027–2032)
4.1.3 Global Low Molecular Weight Heparin API Sales Market Share by Type (2021–2032)
4.2 Global Low Molecular Weight Heparin API Revenue by Type (2021–2032)
4.2.1 Global Low Molecular Weight Heparin API Revenue by Type (2021–2026)
4.2.2 Global Low Molecular Weight Heparin API Revenue by Type (2027–2032)
4.2.3 Global Low Molecular Weight Heparin API Revenue Market Share by Type (2021–2032)
4.3 Global Low Molecular Weight Heparin API Price by Type (2021–2032)
5 Segment by Application
5.1 Global Low Molecular Weight Heparin API Sales by Application (2021–2032)
5.1.1 Global Low Molecular Weight Heparin API Sales by Application (2021–2026)
5.1.2 Global Low Molecular Weight Heparin API Sales by Application (2027–2032)
5.1.3 Global Low Molecular Weight Heparin API Sales Market Share by Application (2021–2032)
5.2 Global Low Molecular Weight Heparin API Revenue by Application (2021–2032)
5.2.1 Global Low Molecular Weight Heparin API Revenue by Application (2021–2026)
5.2.2 Global Low Molecular Weight Heparin API Revenue by Application (2027–2032)
5.2.3 Global Low Molecular Weight Heparin API Revenue Market Share by Application (2021–2032)
5.3 Global Low Molecular Weight Heparin API Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Yantai Dongcheng Pharmaceutical
6.1.1 Yantai Dongcheng Pharmaceutical Company Information
6.1.2 Yantai Dongcheng Pharmaceutical Description and Business Overview
6.1.3 Yantai Dongcheng Pharmaceutical Low Molecular Weight Heparin API Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Yantai Dongcheng Pharmaceutical Low Molecular Weight Heparin API Product Portfolio
6.1.5 Yantai Dongcheng Pharmaceutical Recent Developments/Updates
6.2 Shenzhen Hepalink Pharmaceutical
6.2.1 Shenzhen Hepalink Pharmaceutical Company Information
6.2.2 Shenzhen Hepalink Pharmaceutical Description and Business Overview
6.2.3 Shenzhen Hepalink Pharmaceutical Low Molecular Weight Heparin API Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Shenzhen Hepalink Pharmaceutical Low Molecular Weight Heparin API Product Portfolio
6.2.5 Shenzhen Hepalink Pharmaceutical Recent Developments/Updates
6.3 Nanjing King-friend
6.3.1 Nanjing King-friend Company Information
6.3.2 Nanjing King-friend Description and Business Overview
6.3.3 Nanjing King-friend Low Molecular Weight Heparin API Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Nanjing King-friend Low Molecular Weight Heparin API Product Portfolio
6.3.5 Nanjing King-friend Recent Developments/Updates
6.4 Changzhou Qianhong Biopharma
6.4.1 Changzhou Qianhong Biopharma Company Information
6.4.2 Changzhou Qianhong Biopharma Description and Business Overview
6.4.3 Changzhou Qianhong Biopharma Low Molecular Weight Heparin API Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Changzhou Qianhong Biopharma Low Molecular Weight Heparin API Product Portfolio
6.4.5 Changzhou Qianhong Biopharma Recent Developments/Updates
6.5 Qingdao Jiulong Biopharmaceutical
6.5.1 Qingdao Jiulong Biopharmaceutical Company Information
6.5.2 Qingdao Jiulong Biopharmaceutical Description and Business Overview
6.5.3 Qingdao Jiulong Biopharmaceutical Low Molecular Weight Heparin API Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Qingdao Jiulong Biopharmaceutical Low Molecular Weight Heparin API Product Portfolio
6.5.5 Qingdao Jiulong Biopharmaceutical Recent Developments/Updates
6.6 Dongying Tiandong Pharmaceutical
6.6.1 Dongying Tiandong Pharmaceutical Company Information
6.6.2 Dongying Tiandong Pharmaceutical Description and Business Overview
6.6.3 Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin API Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin API Product Portfolio
6.6.5 Dongying Tiandong Pharmaceutical Recent Developments/Updates
6.7 Yino Pharma
6.7.1 Yino Pharma Company Information
6.7.2 Yino Pharma Description and Business Overview
6.7.3 Yino Pharma Low Molecular Weight Heparin API Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Yino Pharma Low Molecular Weight Heparin API Product Portfolio
6.7.5 Yino Pharma Recent Developments/Updates
6.8 Opocrin
6.8.1 Opocrin Company Information
6.8.2 Opocrin Description and Business Overview
6.8.3 Opocrin Low Molecular Weight Heparin API Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Opocrin Low Molecular Weight Heparin API Product Portfolio
6.8.5 Opocrin Recent Developments/Updates
6.9 Hebei Changshan
6.9.1 Hebei Changshan Company Information
6.9.2 Hebei Changshan Description and Business Overview
6.9.3 Hebei Changshan Low Molecular Weight Heparin API Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Hebei Changshan Low Molecular Weight Heparin API Product Portfolio
6.9.5 Hebei Changshan Recent Developments/Updates
6.10 Hubei Enoray Biopharmaceutical
6.10.1 Hubei Enoray Biopharmaceutical Company Information
6.10.2 Hubei Enoray Biopharmaceutical Description and Business Overview
6.10.3 Hubei Enoray Biopharmaceutical Low Molecular Weight Heparin API Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Hubei Enoray Biopharmaceutical Low Molecular Weight Heparin API Product Portfolio
6.10.5 Hubei Enoray Biopharmaceutical Recent Developments/Updates
6.11 Nanjing Nanda Pharmaceutical
6.11.1 Nanjing Nanda Pharmaceutical Company Information
6.11.2 Nanjing Nanda Pharmaceutical Description and Business Overview
6.11.3 Nanjing Nanda Pharmaceutical Low Molecular Weight Heparin API Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Nanjing Nanda Pharmaceutical Low Molecular Weight Heparin API Product Portfolio
6.11.5 Nanjing Nanda Pharmaceutical Recent Developments/Updates
6.12 Cisen Pharmaceutical
6.12.1 Cisen Pharmaceutical Company Information
6.12.2 Cisen Pharmaceutical Description and Business Overview
6.12.3 Cisen Pharmaceutical Low Molecular Weight Heparin API Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Cisen Pharmaceutical Low Molecular Weight Heparin API Product Portfolio
6.12.5 Cisen Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Low Molecular Weight Heparin API Industry Chain Analysis
7.2 Low Molecular Weight Heparin API Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Low Molecular Weight Heparin API Production Mode & Process Analysis
7.4 Low Molecular Weight Heparin API Sales and Marketing
7.4.1 Low Molecular Weight Heparin API Sales Channels
7.4.2 Low Molecular Weight Heparin API Distributors
7.5 Low Molecular Weight Heparin API Customer Analysis
8 Low Molecular Weight Heparin API Market Dynamics
8.1 Low Molecular Weight Heparin API Industry Trends
8.2 Low Molecular Weight Heparin API Market Drivers
8.3 Low Molecular Weight Heparin API Market Challenges
8.4 Low Molecular Weight Heparin API Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Low Molecular Weight Heparin API Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Low Molecular Weight Heparin API Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Low Molecular Weight Heparin API Market Competitive Situation by Manufacturers in 2025
Table 4. Global Low Molecular Weight Heparin API Sales (Billion Units) of Key Manufacturers (2021–2026)
Table 5. Global Low Molecular Weight Heparin API Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Low Molecular Weight Heparin API Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Low Molecular Weight Heparin API Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Low Molecular Weight Heparin API Average Price (US$/Billion Untis) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Low Molecular Weight Heparin API, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Low Molecular Weight Heparin API, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Low Molecular Weight Heparin API, Product Types and Applications
Table 12. Global Key Manufacturers of Low Molecular Weight Heparin API, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Low Molecular Weight Heparin API Companies by Tier (Tier 1, Tier 2, Tier 3), based on Low Molecular Weight Heparin API Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Low Molecular Weight Heparin API Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Low Molecular Weight Heparin API Sales by Region (Billion Units), 2021–2026
Table 18. Global Low Molecular Weight Heparin API Sales Market Share by Region (2021–2026)
Table 19. Global Low Molecular Weight Heparin API Sales by Region (Billion Units), 2027–2032
Table 20. Global Low Molecular Weight Heparin API Sales Market Share by Region (2027–2032)
Table 21. Global Low Molecular Weight Heparin API Revenue by Region (US$ Million), 2021–2026
Table 22. Global Low Molecular Weight Heparin API Revenue Market Share by Region (2021–2026)
Table 23. Global Low Molecular Weight Heparin API Revenue by Region (US$ Million), 2027–2032
Table 24. Global Low Molecular Weight Heparin API Revenue Market Share by Region (2027–2032)
Table 25. North America Low Molecular Weight Heparin API Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Low Molecular Weight Heparin API Sales by Country (Billion Units), 2021–2026
Table 27. North America Low Molecular Weight Heparin API Sales by Country (Billion Units), 2027–2032
Table 28. North America Low Molecular Weight Heparin API Revenue by Country (US$ Million), 2021–2026
Table 29. North America Low Molecular Weight Heparin API Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Low Molecular Weight Heparin API Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Low Molecular Weight Heparin API Sales by Country (Billion Units), 2021–2026
Table 32. Europe Low Molecular Weight Heparin API Sales by Country (Billion Units), 2027–2032
Table 33. Europe Low Molecular Weight Heparin API Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Low Molecular Weight Heparin API Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Low Molecular Weight Heparin API Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Low Molecular Weight Heparin API Sales by Region (Billion Units), 2021–2026
Table 37. Asia Pacific Low Molecular Weight Heparin API Sales by Region (Billion Units), 2027–2032
Table 38. Asia Pacific Low Molecular Weight Heparin API Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Low Molecular Weight Heparin API Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Low Molecular Weight Heparin API Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Low Molecular Weight Heparin API Sales by Country (Billion Units), 2021–2026
Table 42. Latin America Low Molecular Weight Heparin API Sales by Country (Billion Units), 2027–2032
Table 43. Latin America Low Molecular Weight Heparin API Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Low Molecular Weight Heparin API Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Low Molecular Weight Heparin API Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Low Molecular Weight Heparin API Sales by Country (Billion Units), 2021–2026
Table 47. Middle East and Africa Low Molecular Weight Heparin API Sales by Country (Billion Units), 2027–2032
Table 48. Middle East and Africa Low Molecular Weight Heparin API Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Low Molecular Weight Heparin API Revenue by Country (US$ Million), 2027–2032
Table 50. Global Low Molecular Weight Heparin API Sales (Billion Units) by Type (2021–2026)
Table 51. Global Low Molecular Weight Heparin API Sales (Billion Units) by Type (2027–2032)
Table 52. Global Low Molecular Weight Heparin API Sales Market Share by Type (2021–2026)
Table 53. Global Low Molecular Weight Heparin API Sales Market Share by Type (2027–2032)
Table 54. Global Low Molecular Weight Heparin API Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Low Molecular Weight Heparin API Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Low Molecular Weight Heparin API Revenue Market Share by Type (2021–2026)
Table 57. Global Low Molecular Weight Heparin API Revenue Market Share by Type (2027–2032)
Table 58. Global Low Molecular Weight Heparin API Price (US$/Billion Untis) by Type (2021–2026)
Table 59. Global Low Molecular Weight Heparin API Price (US$/Billion Untis) by Type (2027–2032)
Table 60. Global Low Molecular Weight Heparin API Sales (Billion Units) by Application (2021–2026)
Table 61. Global Low Molecular Weight Heparin API Sales (Billion Units) by Application (2027–2032)
Table 62. Global Low Molecular Weight Heparin API Sales Market Share by Application (2021–2026)
Table 63. Global Low Molecular Weight Heparin API Sales Market Share by Application (2027–2032)
Table 64. Global Low Molecular Weight Heparin API Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Low Molecular Weight Heparin API Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Low Molecular Weight Heparin API Revenue Market Share by Application (2021–2026)
Table 67. Global Low Molecular Weight Heparin API Revenue Market Share by Application (2027–2032)
Table 68. Global Low Molecular Weight Heparin API Price (US$/Billion Untis) by Application (2021–2026)
Table 69. Global Low Molecular Weight Heparin API Price (US$/Billion Untis) by Application (2027–2032)
Table 70. Yantai Dongcheng Pharmaceutical Company Information
Table 71. Yantai Dongcheng Pharmaceutical Description and Business Overview
Table 72. Yantai Dongcheng Pharmaceutical Low Molecular Weight Heparin API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Untis), and Gross Margin (2021–2026)
Table 73. Yantai Dongcheng Pharmaceutical Low Molecular Weight Heparin API Product
Table 74. Yantai Dongcheng Pharmaceutical Recent Developments/Updates
Table 75. Shenzhen Hepalink Pharmaceutical Company Information
Table 76. Shenzhen Hepalink Pharmaceutical Description and Business Overview
Table 77. Shenzhen Hepalink Pharmaceutical Low Molecular Weight Heparin API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Untis), and Gross Margin (2021–2026)
Table 78. Shenzhen Hepalink Pharmaceutical Low Molecular Weight Heparin API Product
Table 79. Shenzhen Hepalink Pharmaceutical Recent Developments/Updates
Table 80. Nanjing King-friend Company Information
Table 81. Nanjing King-friend Description and Business Overview
Table 82. Nanjing King-friend Low Molecular Weight Heparin API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Untis), and Gross Margin (2021–2026)
Table 83. Nanjing King-friend Low Molecular Weight Heparin API Product
Table 84. Nanjing King-friend Recent Developments/Updates
Table 85. Changzhou Qianhong Biopharma Company Information
Table 86. Changzhou Qianhong Biopharma Description and Business Overview
Table 87. Changzhou Qianhong Biopharma Low Molecular Weight Heparin API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Untis), and Gross Margin (2021–2026)
Table 88. Changzhou Qianhong Biopharma Low Molecular Weight Heparin API Product
Table 89. Changzhou Qianhong Biopharma Recent Developments/Updates
Table 90. Qingdao Jiulong Biopharmaceutical Company Information
Table 91. Qingdao Jiulong Biopharmaceutical Description and Business Overview
Table 92. Qingdao Jiulong Biopharmaceutical Low Molecular Weight Heparin API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Untis), and Gross Margin (2021–2026)
Table 93. Qingdao Jiulong Biopharmaceutical Low Molecular Weight Heparin API Product
Table 94. Qingdao Jiulong Biopharmaceutical Recent Developments/Updates
Table 95. Dongying Tiandong Pharmaceutical Company Information
Table 96. Dongying Tiandong Pharmaceutical Description and Business Overview
Table 97. Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Untis), and Gross Margin (2021–2026)
Table 98. Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin API Product
Table 99. Dongying Tiandong Pharmaceutical Recent Developments/Updates
Table 100. Yino Pharma Company Information
Table 101. Yino Pharma Description and Business Overview
Table 102. Yino Pharma Low Molecular Weight Heparin API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Untis), and Gross Margin (2021–2026)
Table 103. Yino Pharma Low Molecular Weight Heparin API Product
Table 104. Yino Pharma Recent Developments/Updates
Table 105. Opocrin Company Information
Table 106. Opocrin Description and Business Overview
Table 107. Opocrin Low Molecular Weight Heparin API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Untis), and Gross Margin (2021–2026)
Table 108. Opocrin Low Molecular Weight Heparin API Product
Table 109. Opocrin Recent Developments/Updates
Table 110. Hebei Changshan Company Information
Table 111. Hebei Changshan Description and Business Overview
Table 112. Hebei Changshan Low Molecular Weight Heparin API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Untis), and Gross Margin (2021–2026)
Table 113. Hebei Changshan Low Molecular Weight Heparin API Product
Table 114. Hebei Changshan Recent Developments/Updates
Table 115. Hubei Enoray Biopharmaceutical Company Information
Table 116. Hubei Enoray Biopharmaceutical Description and Business Overview
Table 117. Hubei Enoray Biopharmaceutical Low Molecular Weight Heparin API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Untis), and Gross Margin (2021–2026)
Table 118. Hubei Enoray Biopharmaceutical Low Molecular Weight Heparin API Product
Table 119. Hubei Enoray Biopharmaceutical Recent Developments/Updates
Table 120. Nanjing Nanda Pharmaceutical Company Information
Table 121. Nanjing Nanda Pharmaceutical Description and Business Overview
Table 122. Nanjing Nanda Pharmaceutical Low Molecular Weight Heparin API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Untis), and Gross Margin (2021–2026)
Table 123. Nanjing Nanda Pharmaceutical Low Molecular Weight Heparin API Product
Table 124. Nanjing Nanda Pharmaceutical Recent Developments/Updates
Table 125. Cisen Pharmaceutical Company Information
Table 126. Cisen Pharmaceutical Description and Business Overview
Table 127. Cisen Pharmaceutical Low Molecular Weight Heparin API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Untis), and Gross Margin (2021–2026)
Table 128. Cisen Pharmaceutical Low Molecular Weight Heparin API Product
Table 129. Cisen Pharmaceutical Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Low Molecular Weight Heparin API Distributors List
Table 133. Low Molecular Weight Heparin API Customers List
Table 134. Low Molecular Weight Heparin API Market Trends
Table 135. Low Molecular Weight Heparin API Market Drivers
Table 136. Low Molecular Weight Heparin API Market Challenges
Table 137. Low Molecular Weight Heparin API Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
Table 141. Authors List of This Report
List of Figures
Figure 1. Product Picture of Low Molecular Weight Heparin API
Figure 2. Global Low Molecular Weight Heparin API Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Low Molecular Weight Heparin API Market Share by Type: 2025 & 2032
Figure 4. Low Molecular Weight Heparin Sodium Product Picture
Figure 5. Low Molecular Weight Heparin Calcium Product Picture
Figure 6. Global Low Molecular Weight Heparin API Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Low Molecular Weight Heparin API Market Share by Application: 2025 & 2032
Figure 8. Enoxaparin Sodium
Figure 9. Nadroparin Calcium
Figure 10. Dalteparin Sodium
Figure 11. Tinzaparin Sodium
Figure 12. Parnaparin Sodium
Figure 13. Global Low Molecular Weight Heparin API Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Low Molecular Weight Heparin API Market Size (US$ Million), 2021–2032
Figure 15. Global Low Molecular Weight Heparin API Sales (Billion Units), 2021–2032
Figure 16. Global Low Molecular Weight Heparin API Average Price (US$/Billion Untis), 2021–2032
Figure 17. Low Molecular Weight Heparin API Report Years Considered
Figure 18. Low Molecular Weight Heparin API Sales Share by Manufacturers in 2025
Figure 19. Global Low Molecular Weight Heparin API Revenue Share by Manufacturers in 2025
Figure 20. Top 5 and Top 10 Global Low Molecular Weight Heparin API Players: Market Share by Revenue in Low Molecular Weight Heparin API in 2025
Figure 21. Low Molecular Weight Heparin API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 22. Global Low Molecular Weight Heparin API Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 23. North America Low Molecular Weight Heparin API Sales Market Share by Country (2021–2032)
Figure 24. North America Low Molecular Weight Heparin API Revenue Market Share by Country (2021–2032)
Figure 25. United States Low Molecular Weight Heparin API Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Canada Low Molecular Weight Heparin API Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Europe Low Molecular Weight Heparin API Sales Market Share by Country (2021–2032)
Figure 28. Europe Low Molecular Weight Heparin API Revenue Market Share by Country (2021–2032)
Figure 29. Germany Low Molecular Weight Heparin API Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. France Low Molecular Weight Heparin API Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. U.K. Low Molecular Weight Heparin API Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Italy Low Molecular Weight Heparin API Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Russia Low Molecular Weight Heparin API Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Asia Pacific Low Molecular Weight Heparin API Sales Market Share by Region (2021–2032)
Figure 35. Asia Pacific Low Molecular Weight Heparin API Revenue Market Share by Region (2021–2032)
Figure 36. China Low Molecular Weight Heparin API Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Japan Low Molecular Weight Heparin API Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. South Korea Low Molecular Weight Heparin API Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. India Low Molecular Weight Heparin API Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Australia Low Molecular Weight Heparin API Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. China Taiwan Low Molecular Weight Heparin API Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Southeast Asia Low Molecular Weight Heparin API Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Latin America Low Molecular Weight Heparin API Sales Market Share by Country (2021–2032)
Figure 44. Latin America Low Molecular Weight Heparin API Revenue Market Share by Country (2021–2032)
Figure 45. Mexico Low Molecular Weight Heparin API Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Brazil Low Molecular Weight Heparin API Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Argentina Low Molecular Weight Heparin API Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Colombia Low Molecular Weight Heparin API Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Middle East and Africa Low Molecular Weight Heparin API Sales Market Share by Country (2021–2032)
Figure 50. Middle East and Africa Low Molecular Weight Heparin API Revenue Market Share by Country (2021–2032)
Figure 51. Turkey Low Molecular Weight Heparin API Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Saudi Arabia Low Molecular Weight Heparin API Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. UAE Low Molecular Weight Heparin API Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Global Sales Market Share of Low Molecular Weight Heparin API by Type (2021–2032)
Figure 55. Global Revenue Market Share of Low Molecular Weight Heparin API by Type (2021–2032)
Figure 56. Global Low Molecular Weight Heparin API Price (US$/Billion Untis) by Type (2021–2032)
Figure 57. Global Sales Market Share of Low Molecular Weight Heparin API by Application (2021–2032)
Figure 58. Global Revenue Market Share of Low Molecular Weight Heparin API by Application (2021–2032)
Figure 59. Global Low Molecular Weight Heparin API Price (US$/Billion Untis) by Application (2021–2032)
Figure 60. Low Molecular Weight Heparin API Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
